Benefits from optimised antihypertensive and statin treatment in high risk people
dc.contributor.author | Wu, R | en_US |
dc.contributor.author | Rison, S | en_US |
dc.contributor.author | Raisi-Estabragh, Z | en_US |
dc.contributor.author | Dostal, I | en_US |
dc.contributor.author | Carvalho, C | en_US |
dc.contributor.author | Robson, J | en_US |
dc.contributor.author | Mihaylova, B | en_US |
dc.date.accessioned | 2021-11-02T15:59:35Z | |
dc.date.issued | 2021-10-12 | en_US |
dc.identifier.issn | 0195-668X | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/74955 | |
dc.format.extent | ehab724.2728 - ? | en_US |
dc.relation.ispartof | European Heart Journal | en_US |
dc.title | Benefits from optimised antihypertensive and statin treatment in high risk people | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1093/eurheartj/ehab724.2728 | en_US |
pubs.issue | Supplement_1 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 42 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |